Zevra Therapeutics (ZVRA) Revenue (2019 - 2026)
Zevra Therapeutics (ZVRA) reported Revenue of $39.7 million for Q2 2026, up 53.3% from $25.9 million a year earlier and up 9.6% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Revenue (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Zevra Therapeutics' Revenue came in at $136.18 million, up 119.6% year-over-year; for FY2025, it was $106.5 million, up 351.0% from FY2024.
- Revenue has a five-year compound annual growth rate of 51.6% (FY2020 to FY2025).
- By year, Revenue came in at $23.61 million in FY2024 (-14.0%), $27.46 million in FY2023 (+170.3%), $10.16 million in FY2022 (-64.5%) and $28.65 million in FY2021 (+115.6%).
- The Q2 2026 figure ranks as the highest quarterly Revenue in data going back to Q3 2019.
- Year over year, Revenue has now increased in each of the last six quarters, with growth averaging 239.9% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q3 2025 (growth of 605.4%); the low point was Q2 2022 (a decline of 89.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $36.22 million (Q1 2026), $34.16 million (Q4 2025) and $26.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 39.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.70 Mn |
| Mar 31, 2026 | 36.22 Mn |
| Dec 31, 2025 | 34.16 Mn |
| Sep 30, 2025 | 26.10 Mn |
| Jun 30, 2025 | 25.90 Mn |
| Mar 31, 2025 | 20.40 Mn |
| Dec 31, 2024 | 12.01 Mn |
| Sep 30, 2024 | 3.70 Mn |
| Jun 30, 2024 | 4.45 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 12.92 Mn |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 8.47 Mn |
| Mar 31, 2023 | 3.18 Mn |
| Dec 31, 2022 | 2.02 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 3.97 Mn |
| Dec 31, 2021 | 2.58 Mn |
| Sep 30, 2021 | 1.97 Mn |
API Access
Zevra Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();